Canaccord Genuity Maintains Buy on Stryker, Lowers Price Target to $400

Benzinga Newsdesk www.benzinga.com Negative 60.3%

Neg 60.3% Neu 0% Pos 0%

Canaccord Genuity analyst Kyle Rose maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $435 to $400.